Print
News
Diabetes drug developer Lumena raises $2.5M; compound regulates blood sugar
WRAL Tech Wire
February 21, 2012
Diabetes drug company Lumena raising up to $2M to reach clinical trials
MedCity News
June 24, 2011
Pappas Ventures-Backed Lumena Pharma Bumps up Debt Offering to $2M - cbl
CityBizList
June 17, 2011
Lumena Pharmaceuticals
Durham, NC
Lumena is focused on developing treatments for metabolic diseases through non-systemically absorbed compounds having targets within the lumen of the gut.